Immortalized pancreatic duct cells in vitro and in vivo

被引:14
作者
Jesnowski, R [1 ]
Müller, P [1 ]
Schareck, W [1 ]
Liebe, S [1 ]
Löhr, M [1 ]
机构
[1] Univ Rostock, Div Gastroenterol, Dept Med, D-18057 Rostock, Germany
来源
CELL AND MOLECULAR BIOLOGY OF PANCREATIC CARCINOMA: RECENT DEVELOPMENTS IN RESEARCH AND EXPERIMENTAL THERAPY | 1999年 / 880卷
关键词
D O I
10.1111/j.1749-6632.1999.tb09509.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although pancreatic adenocarcinoma has become one of the best characterized malignant diseases,severe diagnostic and therapeutic problems are still associated with this disease: The establishment of a molecular model of pancreatic carcinogenesis may provide tools that could result in earlier diagnosis of this disease:and, in turn, improves prognosis, Since pancreatic adenocarcinoma seems Ito:originate in epithelial cells in-the pancreatic ducts, cultivation of native pancreatic duct epithelial cells (PDEC) lithe initial. step in the establishment of an in vitro model df pancreatic carcinogenesis. As these I native cells survive only a short period in culture, the aim of this study was to establish a stable pancreatic duct cell line by immortalization with the SV40 large T antigen. Furthermore, initial steps in pancreatic carcinogenesis should. possibly be imitated by additional transfections of mutated ki-ras and/or mutated p53 genes, By optimization of the isolation protocol and the culture medium, yield as well as proliferative activity of isolated PDEC was increased considerably, Transfection bf SV40 large T antigen resulted in an increase in the proliferative:lifetime of the isolated cells, but no real immortal phenotype was obtained, Moreover, one step in the transformation from the normal to the malignant phenotype was imitated successfully by additional transfection of mutated ki-ras.
引用
收藏
页码:50 / 65
页数:16
相关论文
共 66 条
[1]   MOST HUMAN CARCINOMAS OF THE EXOCRINE PANCREAS CONTAIN MUTANT C-K-RAS GENES [J].
ALMOGUERA, C ;
SHIBATA, D ;
FORRESTER, K ;
MARTIN, J ;
ARNHEIM, N ;
PERUCHO, M .
CELL, 1988, 53 (04) :549-554
[2]  
[Anonymous], PANCREAS BIOL PATHOB
[3]  
AUSUBEL FM, 1990, CURRENT PROTOCOLS MO
[4]   CHROMOSOME-17 DELETIONS AND P53 GENE-MUTATIONS IN COLORECTAL CARCINOMAS [J].
BAKER, SJ ;
FEARON, ER ;
NIGRO, JM ;
HAMILTON, SR ;
PREISINGER, AC ;
JESSUP, JM ;
VANTUINEN, P ;
LEDBETTER, DH ;
BARKER, DF ;
NAKAMURA, Y ;
WHITE, R ;
VOGELSTEIN, B .
SCIENCE, 1989, 244 (4901) :217-221
[5]   ALTERED EXPRESSION OF MUC2, MUC4, AND MUC5 MUCIN GENES IN PANCREAS TISSUES AND CANCER CELL-LINES [J].
BALAGUE, C ;
GAMBUS, G ;
CARRATO, C ;
PORCHET, N ;
AUBERT, JP ;
KIM, YS ;
REAL, FX .
GASTROENTEROLOGY, 1994, 106 (04) :1054-1061
[6]   KARYOTYPIC ABNORMALITIES IN TUMORS OF THE PANCREAS [J].
BARDI, G ;
JOHANSSON, B ;
PANDIS, N ;
MANDAHL, N ;
BAKJENSEN, E ;
ANDRENSANDBERG, A ;
MITELMAN, F ;
HEIM, S .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1106-1112
[7]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[8]   CANCER STATISTICS, 1991 [J].
BORING, CC ;
SQUIRES, TS ;
TONG, T .
CA-A CANCER JOURNAL FOR CLINICIANS, 1991, 41 (01) :19-36
[9]  
BOS JL, 1989, CANCER RES, V49, P4682
[10]   CYTOKERATINS AS MARKERS OF DUCTAL CELL-DIFFERENTIATION AND ISLET NEOGENESIS IN THE NEONATAL RAT PANCREAS [J].
BOUWENS, L ;
WANG, RN ;
DEBLAY, E ;
PIPELEERS, DG ;
KLOPPEL, G .
DIABETES, 1994, 43 (11) :1279-1283